Estudio de costo-beneficio del tratamiento profiláctico de la neutropenia febril con pegfilgrastim versus filgrastim en pacientes pediátricos con tumores sólidos

Norma Araceli López-Facundo, Department of Pediatric Oncology, Hospital Materno-Infantil, ISSEMYM, Toluca, Estado de México, Mexico
Ma. Guadalupe Valois-Escamilla, Pediatrics Department, Hospital Materno-Infantil, ISSEMYM, Toluca, Estado de México, Mexico
Isidoro Tejocote-Romero, Department of Pediatric Oncology, Hospital Materno-Infantil, ISSEMYM, Toluca, Estado de México, Mexico
Cecilia Rodríguez-Castillejos, Department of Pediatric Hematology, Hospital Materno-Infantil, ISSEMYM, Toluca, Estado de México, Mexico
Yanet Jaimes-García, Department of Pediatric Oncology, Hospital Materno-Infantil, ISSEMYM, Toluca, Estado de México, Mexico